C. Michael Gibson reports that a hybrid AI-human approach reproduced a trial primary endpoint and effect size and outperformed GPT-4 alone, suggesting AI works best as adjudication support rather than full automation.
discuss the use of AI for cardiovascular event adjudication:
A hybrid AI-human approach effectively reproduced original trial primary endpoint and effect size, outperforming GPT-4 alone.
#ACC26
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare